Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb) V For The Active Ingredient Abatacept - Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb) V For The Active Ingredient Agalsidase Beta - Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb) V For The Active Ingredient Tobramycin (hpi) - Vv 80 2026-08-10
Finland Digital Doctor Service (dps) 2026-08-24
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Drospirenone And Ethinylestradiol (atc Code 2026-08-27
United States Open Enrollment - Clinical Examiners 2026-08-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Sulfasalazine (m01cx02) Within The Framework Of A So-called Open House Model. 2026-08-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Clobetasol (d07ad01) Within The Framework Of A So-called Open House Model. 2026-08-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Erythropoietin (b03xa01) Within The Framework Of A So-called Open House Model. 2026-08-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Bosutinib (l01ea04) Within The Framework Of A So-called Open House Model. 2026-08-31
Whats app